Because the anti-cancer function of UBXN2A is mediated through mot-2-p53, we hypothesized that UBXN2A induction would potentiate the cytotoxic effects of standard chemotherapy which cause DNA damage and activate pathways that signal to p53 [2]. This evidence concerns the gene HSPA9 and cancer.